BeiGene Ltd (HK:6160) has released an update.
BeiGene Ltd, a biotech firm originally incorporated in the Cayman Islands, has announced plans to relocate its domicile to Switzerland, a move that will not affect its business operations or stock listings on Nasdaq, HKEx, and the STAR Market. The company will hold an Extraordinary General Meeting (EGM) for shareholders to approve the domicile change, the adoption of new Swiss articles of association, and the appointment of Ernst & Young AG as its Swiss statutory auditor. Shareholders are advised to read the forthcoming circular detailing the proposals and exercise caution when dealing in the company’s securities.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.